Gynecologic oncology reports
Gynecologic oncology reports
Audio Summaries
Every issue of Gynecologic oncology reports moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Specialties
Gynecologic oncology reports covers research in these specialties.
Recent summaries
The latest articles summarized from Gynecologic oncology reports.
Malignant transformation of a testosterone-secreting ovarian steroid cell tumor: a case report
May 7, 2026
This case report investigates the malignant transformation of a testosterone-secreting ovarian steroid cell tumor (SCT-NOS) in a 41-year-old woman, initially presenting with benign features but later developing malignant characteristics after three years. The authors aim to highlight the potential for malignant recurrence in SCT-NOS, the associated molecular alterations, and the challenges in managing such cases despite surgical and chemotherapeutic interventions. The findings underscore the need for improved risk stratification and novel treatment strategies for this rare tumor type.
Real World Outcomes of Pembrolizumab and Reduced-Dose Lenvatinib in Recurrent Endometrial Cancer by Platinum and p53 Status
May 7, 2026
This study aimed to evaluate the efficacy of pembrolizumab and reduced-dose lenvatinib in patients with recurrent endometrial cancer, specifically examining outcomes based on platinum resistance and p53 mutation status. The findings indicated that a lower starting dose of lenvatinib (≤10 mg) was non-inferior to higher doses in terms of objective response rate and was better tolerated, while p53 mutation status was associated with improved progression-free survival. These results support the potential for individualized dosing strategies and highlight p53 mutation as a possible predictive biomarker in this patient population.
Risk of venous thromboembolism following human papillomavirus vaccination: a systematic review and meta-analysis
May 7, 2026
The authors aimed to evaluate the potential association between human papillomavirus (HPV) vaccination and the risk of venous thromboembolism (VTE) through a systematic review and meta-analysis of observational studies. Their analysis, which included millions of participants, found no statistically significant link between HPV vaccination and VTE risk, reinforcing the favorable safety profile of HPV vaccines across various demographics.
Fertility desires and outcomes in patients with selected hereditary cancer syndromes
May 6, 2026
This study investigates the fertility desires and pregnancy outcomes among women with newly diagnosed BRCA1, BRCA2, MLH1, and MSH2 mutations, aiming to identify gaps in counseling and referral for fertility services. The findings reveal that while a significant portion of women expressed a desire for future fertility, referral rates to reproductive endocrinology and infertility (REI) specialists and the use of assisted reproductive technology (ART) were notably low. The results highlight the need for improved support and resources for young women with hereditary cancer syndromes regarding their reproductive options.
Pathological complete response following systemic therapy with carboplatin-paclitaxel plus pembrolizumab for initially unresectable mismatch repair-deficient advanced endometrial cancer: two case reports
May 6, 2026
This study investigates the effectiveness of carboplatin-paclitaxel combined with pembrolizumab in achieving a pathological complete response (pCR) in patients with initially unresectable mismatch repair-deficient (dMMR) advanced endometrial cancer. The authors present two case reports where patients achieved pCR following this systemic therapy, suggesting that this treatment approach may allow for less invasive surgical options. The findings highlight the potential of chemo-immunotherapy to improve treatment outcomes in advanced dMMR endometrial cancer.
The challenges of implementing less invasive surgical management for cervical cancer in a limited-resource setting in Botswana: A case series
May 4, 2026
This case series investigates the feasibility of implementing less invasive surgical management, specifically simple hysterectomy (SH), for early-stage cervical cancer in Botswana, where there is a critical shortage of gynecologic oncologists. The authors assess the accuracy of clinical and imaging-based staging for risk stratification and identify significant challenges, including delays in care and the reliability of staging, that hinder the adoption of SH in a limited-resource setting.
Primary extranodal marginal zone B-cell lymphoma of the ovary, fallopian tube, and uterus: A rare case report and review of the literature
May 1, 2026
The authors aim to highlight the rarity of primary extranodal marginal zone B-cell lymphoma (EMZL) occurring in the ovary, fallopian tube, and uterus, as only a few cases have been documented in the literature. They present a case of a 78-year-old female diagnosed with EMZL following surgical intervention, emphasizing the importance of considering this diagnosis when atypical lymphoid cells are observed in surgical specimens. The case underscores the need for awareness of EMZL as a potential diagnosis in gynecological pathology.
Recent national trends in pelvic and paraaortic lymphadenectomy in gynecologic oncology fellowship training programs: ACGME data from 2019-2025
May 1, 2026
The authors aimed to investigate trends in the surgical experience of gynecologic oncology fellows in the U.S. regarding pelvic and paraaortic lymphadenectomies from 2019 to 2025. They found a significant decline in the number of these procedures performed by fellows, alongside an increase in sentinel lymph node (SNL) procedures, suggesting potential implications for training in radical pelvic surgery.
Correlation of patient reported outcomes and physical exam screening for pelvic floor dysfunction: An opportunity for improved quality of life during chemoradiotherapy for cervical cancer
May 1, 2026
The authors aimed to define the prevalence and time course of pelvic floor dysfunction (PFD) in cervical cancer patients undergoing chemoradiotherapy (CRT). They found that 50% of patients had PFD at baseline, which improved to 25% by follow-up, and identified that the EORTC QLQ-CX24 patient-reported outcome measure correlated well with physical exam findings, suggesting its potential as a monitoring tool for PFD. The study highlights the need for further research on early intervention strategies for patients with pre-existing PFD.
An unforgiving sequela: recurrent radiation-associated sarcoma of the vulva
Apr 30, 2026
The authors aim to highlight the aggressive nature and clinical challenges associated with radiation-associated sarcomas of the vulva, as demonstrated through a case study of a 64-year-old woman who developed a high-grade sarcoma following treatment for squamous cell carcinoma. Despite multiple surgical interventions achieving negative margins, the patient experienced rapid local recurrence and eventual metastasis, underscoring the need for early detection, close monitoring, and a multidisciplinary approach to management. The study calls for further research to establish effective treatment strategies for this rare and complex malignancy.